WallStreetZenWallStreetZen

NYSEMKT: CLDI
Calidi Biotherapeutics Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

CLDI past revenue growth

How has CLDI's revenue growth performed historically?
Company
-100%
Industry
99.5%
Market
13.73%
CLDI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CLDI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

CLDI earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$8.6M
Current Profit Margin
0%

CLDI Return on Equity

Insufficient data to display

Be the first to know when CLDI announces earnings.

CLDI Return on Assets

Current Company
-19.9%
Current Industry
-1.5%
CLDI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CLDI Return on Capital Employed

Current Company
-22.6%
Current Industry
11.8%

CLDI vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CLDI$0.00-$8.10M-$8.59M-100.00%N/A
INAB$0.00-$28.61M-$30.44MN/AN/A
SABS$6.42M-$25.18M-$29.19M-71.38%N/A
ALGS$17.25M-$81.27M-$82.25M+165.09%N/A
KA$4.72M-$48.65M-$51.25M-1.00%N/A
View Top Biotech Stocks

Calidi Biotherapeutics Earnings & Revenue FAQ

What were CLDI's earnings last quarter?

Calidi Biotherapeutics (NYSEMKT: CLDI) reported Q2 2023 earnings per share (EPS) of -$0.46, up 428.57% year over year. Total Calidi Biotherapeutics earnings for the quarter were -$4.27 million. In the same quarter last year, Calidi Biotherapeutics's earnings per share (EPS) was $0.14.

If you're new to stock investing, here's how to buy Calidi Biotherapeutics stock.

What was CLDI's earnings growth in the past year?

As of Q4 2023, Calidi Biotherapeutics's earnings has grown year over year. Calidi Biotherapeutics's earnings in the past year totalled -$8.59 million.

What was CLDI's revenue last quarter?

Calidi Biotherapeutics (NYSEMKT: CLDI) reported Q2 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Calidi Biotherapeutics's revenue was $0.00.

What was CLDI's revenue growth in the past year?

As of Q4 2023, Calidi Biotherapeutics's revenue has grown -100% year over year. This is 199.5 percentage points lower than the US Biotechnology industry revenue growth rate of 99.5%. Calidi Biotherapeutics's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.